RenalGuard Solutions

KIDNEY Clinical Trial Results: RenalGuard Therapy ® Prevents Acute Kidney Injury after Cardiac Surgery. Read more at renalguard.com/press_release/…. #RenalGuard #ActiveKidneyProtection #ContrastInducedNephropathy #RenalGuardTherapy #cardiacsurgery #PreventAKI

RenalGuard Therapy Prevents Acute Kidney Injury after Cardiac Surgery renalguard.com/press_release/…

NNT: 9 patients; the number needed to treat with #RenalGuard automated diuresis to help prevent #cardiacsurgery-associatedAKI #ASN #kidneywk

#KIDNEY trial: #RenalGuard automated diuresis significantly reduces #AKI after #cardiac surgery. #Post-opAKI significantly lower in RenalGuard group vs. standard hydration, 10% vs. 20.9%. #ASN #kidneywk

Late-breaking #KIDNEY #clintrial results this morning at 10:00, Exhibit Halls/AB. #AKI prevalent in cardiac surgery, occurring in 30 percent of cases and 50-70 percent of emergent cases. Can it be reduced? Poster TH-PO1183. #ASN #kidneywk

Hope to see you tomorrow 10:00 am; #latebreaking #clintrial TH-PO1183. Kidney protection using the #RenalGuard System in Cardiac Surgery (KIDNEY Study)…assessing #AKI rates; randomized controlled 220-patient trial. #ASN #kidneywk

#Cardiac surgery with less #AKI? Late-breaking presentation: #KIDNEY trial results tomorrow @ASN 10:00 am. Promising #RenalGuard automated diuresis medtech. #ASN #kidneywk

Late Breaking Clinical Trial Results from TCT! prnewswire.com/news-releases/…

Late-Breaking REMEDIAL III Clinical Trial Presented at TCT Shows RenalGuard Therapy's Automated, Personalized Hydr... prn.to/2IlAjqD

Watch my interview with Dr. Carlo Briguori where he explains the results of REMEDIAL III presented at #TCT2019. tv.clinicaltrialresults.org/play.php?submi…

REMEDIAL III slides presented at #TCT2019 outlining a randomized trial of Urine Flow Rate-Guided vs LVEDP-Guided Hydration. UFR-guided approach is superior in preventing CI-AKI in high-risk patients. Full slide deck: clinicaltrialresults.org/Slides/TCT2019…

Latest podcast by @medtechconf featuring Jim Dillon, CEO, @ReprieveCardio and @RenalGuard medtechconference.com/renal-guard-ce… … #heartfailure #reprievecardio #renalguard

Prof. Ponikowski explains why his late-breaking results from ESC-HF make him optimistic about the potential for @RenalGuard system to help decongest heart failure patients w/ fluid overload. #ADHF #heartfailure vimeo.com/273359320

Watch how RenalGuard-Guided Diuretic Therapy is is designed to work for #heartfailure and #AKI patients in our animation video here. #HeartFailure2018 vimeo.com/272079141/f0da…

We presented #latebreaking data at @escardio #HeartFailure2018 that demonstrated potential benefits of RenalGuard-Guided Diuretic Therapy for #heartfailure. Check out the press release for full details here. renalguard.com/media-center/c…

We’re excited to announce #RenalGuard is being used for kidney protection in a live case at @OptimalCTO by Dr. Javier Escaned. #CTOCONF18

RenalGuard touts ADHF treatment feasibility study data ift.tt/2ISCB2O #meddevice

New Study Demonstrates Feasibility of Using RenalGuard-Guided Diuretic Therapy f ow.ly/7X0N30keZ9x

The device, the RenalGuard-Guided Diuretic Therapy, was proven to optimize fluid management in acute decompensated heart failure patients while alleviating related symptoms. ow.ly/4Ove30keZ8o

Cogmedix is proud to have a long standing relationship with RenalGuard Solutions, working with them to manufacture their critical life-saving #MedicalDevices Congratulations to RenalGuard for their recent clinical trial success! buff.ly/2xvn5Vh